Sepsis Enterprises Limited
Regulation of health care, education, cultural and other social services, not incl. social security · Walsall
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2021-03-31
IXBRL · 134 source facts · 28 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 134 source facts · 28 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 63
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0096_09583335_20210331
- Source archive
- Accounts_Monthly_Data-November2021.zip
Accounts to 2016-03-31
IXBRL · 28 source facts · 8 selected values
Not assessedlegacy record
Accounts to 2016-03-31
IXBRL · 28 source facts · 8 selected values
Not assessed
legacy record
- Reporting period
- 2015-05-11 to 2016-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 10
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0037_09583335_20160331
- Source archive
- Accounts_Monthly_Data-December2016.zip
Registered details
09583335- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-05-11
- Jurisdiction
- —
- Registered office
- AZZURRI HOUSE, WALSALL BUSINESS PARK, WALSALL, WEST MIDLANDS, WS9 0RB, ENGLAND
Classification
1 SIC codes84120
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
1 matched grantsDevelopment of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsisInnovate UK · Collaborative R&D · 2023-01-01 – 2024-09-30 · with 4 other participants£35,110awarded
Development of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsis
Innovate UK · Collaborative R&D · 2023-01-01 – 2024-09-30 · with 4 other participants
£35,110
awarded
Cambridge University Hospitals NHS Foundation Trust£109,531
Sepsis Enterprises Limited£35,110